Moreover, decorin restrains angiogenesis by binding to thrombospondin-1, TGFβ, VEGFR-2, and possibly IGF-IR, and then halting tumor growth by antagonizing oncogenic TKRs and angiogenesis [35, 36]. This evidence concerns the gene TGFB1 and neoplasm.